Chimeric antigen receptor T-cell therapy in adults with B-cell acute lymphoblastic leukemia

Chimeric antigen receptor T-cell (CAR-T) therapy has transformed treatment paradigms for relapsed/refractory (r/r) B-cell acute lymphoblastic leukemia (B-ALL) in children and younger adults. We performed a systematic review to investigate the published literature on efficacy and toxicity of CAR-T th...

Descripción completa

Detalles Bibliográficos
Autores principales: Grover, Punita, Veilleux, Olivier, Tian, Lu, Sun, Ryan, Previtera, Melissa, Curran, Emily, Muffly, Lori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905689/
https://www.ncbi.nlm.nih.gov/pubmed/34610109
http://dx.doi.org/10.1182/bloodadvances.2020003482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905689/
https://www.ncbi.nlm.nih.gov/pubmed/34610109
http://dx.doi.org/10.1182/bloodadvances.2020003482

Ejemplares similares